Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Its manufactured and marketed products consist of ORTHOVISC, which is an HA product used in the treatment of some forms of osteoarthritis in humans; AMVISC, AMVISC Plus, STAARVISC-II and ShellGel, each an injectable ophthalmic viscoelastic HA product; HYVISC, which is an HA product used in the treatment of equine osteoarthritis, and INCERT, an HA-based, anti-adhesive for surgical applications. ORTHOVISC mini, a treatment for osteoarthritis targeting small joints is available in Europe. MONOVISC, a single-injection osteoarthritis product based on its cross-linking technology is available in Europe and Turkey.